Intestinal ultrasound images of the sigmoid colon and terminal ileum before (A, B) and following (C, D) treatment with risankizumab. Pretreatment images show increased bowel wall thickness (BWT) >3.0 mm in both segments, with normalization of BWT post-treatment.